These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8264073)
1. Constellation of risks and processes seen in search for Alzheimer's clues. Cotton P JAMA; 1994 Jan; 271(2):89-91. PubMed ID: 8264073 [No Abstract] [Full Text] [Related]
2. [Alzheimer's disease and apolipoprotein E]. Yamaguchi H No To Shinkei; 1996 Nov; 48(11):981-90. PubMed ID: 8951889 [No Abstract] [Full Text] [Related]
3. Apolipoprotein E and Alzheimer's. van Bockxmeer FM Nature; 1995 May; 375(6529):285. PubMed ID: 7753191 [No Abstract] [Full Text] [Related]
4. Apolipoprotein E receptors: linking brain development and Alzheimer's disease. Herz J; Beffert U Nat Rev Neurosci; 2000 Oct; 1(1):51-8. PubMed ID: 11252768 [TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease: a central role for amyloid. Selkoe DJ J Neuropathol Exp Neurol; 1994 Sep; 53(5):438-47. PubMed ID: 8083687 [No Abstract] [Full Text] [Related]
7. Introduction to the special issue on Alzheimer's disease. Pangalos MN; Randall AD Neuropharmacology; 2010; 59(4-5):219-20. PubMed ID: 20728692 [No Abstract] [Full Text] [Related]
8. Amyloid and tau pathology of familial Alzheimer's disease APP/PS1 mouse model in a senescence phenotype background (SAMP8). Porquet D; Andrés-Benito P; Griñán-Ferré C; Camins A; Ferrer I; Canudas AM; Del Valle J; Pallàs M Age (Dordr); 2015 Feb; 37(1):9747. PubMed ID: 25663420 [TBL] [Abstract][Full Text] [Related]
10. [Pathogenesis of Alzheimer's disease]. Alegre M; Noé E; Luquin MR Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714 [TBL] [Abstract][Full Text] [Related]
11. Recent work on Alzheimer's disease transgenics. Duff K Curr Opin Biotechnol; 1998 Dec; 9(6):561-4. PubMed ID: 9889140 [TBL] [Abstract][Full Text] [Related]
12. Activated human microglia stimulate neuroblastoma cells to upregulate production of beta amyloid protein and tau: implications for Alzheimer's disease pathogenesis. Lee M; McGeer E; McGeer PL Neurobiol Aging; 2015 Jan; 36(1):42-52. PubMed ID: 25169677 [TBL] [Abstract][Full Text] [Related]
13. [Cholesterol metabolic disorders and Alzheimer's disease]. Hao JW; Li L Sheng Li Ke Xue Jin Zhan; 2005 Jan; 36(1):64-6. PubMed ID: 15881350 [No Abstract] [Full Text] [Related]
14. Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease. Selkoe DJ Annu Rev Cell Biol; 1994; 10():373-403. PubMed ID: 7888181 [No Abstract] [Full Text] [Related]
15. Apolipoprotein E in Alzheimer's disease: an update. Yu JT; Tan L; Hardy J Annu Rev Neurosci; 2014; 37():79-100. PubMed ID: 24821312 [TBL] [Abstract][Full Text] [Related]
16. [Development of transgenic animal models for Alzheimer's disease]. Watanabe N; Tabira T No To Shinkei; 2001 Sep; 53(9):809-20. PubMed ID: 11596475 [No Abstract] [Full Text] [Related]
17. A hypothesis on the aetiology of Alzheimer's disease: description of a model involving a misfolded chaperone. Liautard JP Med Hypotheses; 1994 Dec; 43(6):372-80. PubMed ID: 7739409 [TBL] [Abstract][Full Text] [Related]
18. The Golgi apparatus and the pathogenesis of Alzheimer's disease. Dal Canto MC Am J Pathol; 1996 Feb; 148(2):355-60. PubMed ID: 8579097 [No Abstract] [Full Text] [Related]
19. Links between ApoE, brain cholesterol metabolism, tau and amyloid beta-peptide in patients with cognitive impairment. Leoni V; Solomon A; Kivipelto M Biochem Soc Trans; 2010 Aug; 38(4):1021-5. PubMed ID: 20658997 [TBL] [Abstract][Full Text] [Related]
20. [Views of the pathogenesis in Alzheimer's disease are changing]. Baumann M; Tienari P; Haltia M Duodecim; 1999; 115(7):767-76. PubMed ID: 11859510 [No Abstract] [Full Text] [Related] [Next] [New Search]